We showed that SIGIRRΔE8 expression promotes the metabolic shift through upregulation of mTOR (suppressing full-length SIGIRR) and/or dysregulation of mitochondrial function (interacting with ATP5A1) to promote survival and proliferation of colon cancer cells. The gene discussed is SIGIRR; the disease is colonic neoplasm.